KETERBUKAAN INFORMASI

PT. TAISHO PHARMACEUTICAL INDONESIA  TBK

 -Dengan ini diumumkan bahwa pada tanggal 20 Februari 2021 Direksi PT. Taisho Pharmaceutical Indonesia Tbk, berkedudukan di Jakarta Selatan dan beralamat di Millennium Centennial Center, Lt. 8, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 (“Perseroan”) menerima surat pengunduran diri dari Osamu Murakami dari jabatannya Komisaris Perseroan efektif tanggal 21 Maret 2025

-Demikian keterbukaan ini disampaikan dalam rangka memenuhi ketentuan Pasal 27 jo. Pasal 9 Peraturan Otoritas Jasa Keuangan Nomor 33/POJK.04/2014 tentang Direksi dan Dewan Komisaris Emiten atau Perusahaan Publik.

 Jakarta, 21 Februari 2025

Direksi Perseroan

DISCLOSURE OF INFORMATION

PT. TAISHO PHARMACEUTICAL INDONESIA TBK

 -It is hereby announced than on 20 February 2025 the Board of Directors of PT. Taisho Pharmaceutical Indonesia Tbk, domiciled in South Jakarta and having its address at Millennium Centennial Center, Lt. 8, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 (the “Company”) received a resignation letter from Mr. Osamu Murakami from his position as a Commissioner of the Company effective on 21 March 2025.

Thus, this disclosure of information is announced for the purpose of compliance with Article 27 in conjunction with Article 9 of the Regulation of the Financial Services Authority Number 33/POJK.04/2014 regarding the Board of Directors and the Board of Commissioners of Issuers of Public Companies.

 Jakarta, 21 February 2025

Board of Directors of the Company